Richters A - Search Results

1

Targeting GSK3 from Ustilago maydis: type-II kinase inhibitors as potential antifungals.

Grütter C, Simard JR, Mayer-Wrangowski SC, Schreier PH, Pérez-Martín J, Richters A, Getlik M, Gutbrod O, Braun CA, Beck ME, Rauh D. Grütter C, et al. Among authors: richters a. ACS Chem Biol. 2012 Jul 20;7(7):1257-67. doi: 10.1021/cb300128b. Epub 2012 May 15. ACS Chem Biol. 2012. PMID: 22545924

2

A chemical genetic approach for covalent inhibition of analogue-sensitive aurora kinase.

Koch A, Rode HB, Richters A, Rauh D, Hauf S. Koch A, et al. Among authors: richters a. ACS Chem Biol. 2012 Apr 20;7(4):723-31. doi: 10.1021/cb200465c. Epub 2012 Feb 1. ACS Chem Biol. 2012. PMID: 22264160

3

Targeting gain of function and resistance mutations in Abl and KIT by hybrid compound design.

Richters A, Ketzer J, Getlik M, Grütter C, Schneider R, Heuckmann JM, Heynck S, Sos ML, Gupta A, Unger A, Schultz-Fademrecht C, Thomas RK, Bauer S, Rauh D. Richters A, et al. J Med Chem. 2013 Jul 25;56(14):5757-72. doi: 10.1021/jm4004076. Epub 2013 Jul 10. J Med Chem. 2013. PMID: 23773153

4

Identification of type II and III DDR2 inhibitors.

Richters A, Nguyen HD, Phan T, Simard JR, Grütter C, Engel J, Rauh D. Richters A, et al. J Med Chem. 2014 May 22;57(10):4252-62. doi: 10.1021/jm500167q. Epub 2014 May 5. J Med Chem. 2014. PMID: 24754677

5

Identification and further development of potent TBK1 inhibitors.

Richters A, Basu D, Engel J, Ercanoglu MS, Balke-Want H, Tesch R, Thomas RK, Rauh D. Richters A, et al. ACS Chem Biol. 2015 Jan 16;10(1):289-98. doi: 10.1021/cb500908d. ACS Chem Biol. 2015. PMID: 25540906

6

Proteus in the world of proteins: conformational changes in protein kinases.

Rabiller M, Getlik M, Klüter S, Richters A, Tückmantel S, Simard JR, Rauh D. Rabiller M, et al. Among authors: richters a. Arch Pharm (Weinheim). 2010 Apr;343(4):193-206. doi: 10.1002/ardp.201000028. Arch Pharm (Weinheim). 2010. PMID: 20336692 Review.

7

De novo design of protein kinase inhibitors by in silico identification of hinge region-binding fragments.

Urich R, Wishart G, Kiczun M, Richters A, Tidten-Luksch N, Rauh D, Sherborne B, Wyatt PG, Brenk R. Urich R, et al. Among authors: richters a. ACS Chem Biol. 2013 May 17;8(5):1044-52. doi: 10.1021/cb300729y. Epub 2013 Mar 27. ACS Chem Biol. 2013. PMID: 23534475 Free PMC article.

8

Structure-based design and synthesis of covalent-reversible inhibitors to overcome drug resistance in EGFR.

Basu D, Richters A, Rauh D. Basu D, et al. Among authors: richters a. Bioorg Med Chem. 2015 Jun 15;23(12):2767-80. doi: 10.1016/j.bmc.2015.04.038. Epub 2015 Apr 23. Bioorg Med Chem. 2015. PMID: 25975640

9

Covalent-Allosteric Kinase Inhibitors.

Weisner J, Gontla R, van der Westhuizen L, Oeck S, Ketzer J, Janning P, Richters A, Mühlenberg T, Fang Z, Taher A, Jendrossek V, Pelly SC, Bauer S, van Otterlo WA, Rauh D. Weisner J, et al. Among authors: richters a. Angew Chem Int Ed Engl. 2015 Aug 24;54(35):10313-6. doi: 10.1002/anie.201502142. Epub 2015 Jun 25. Angew Chem Int Ed Engl. 2015. PMID: 26110718

10

Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach.

Engel J, Richters A, Getlik M, Tomassi S, Keul M, Termathe M, Lategahn J, Becker C, Mayer-Wrangowski S, Grütter C, Uhlenbrock N, Krüll J, Schaumann N, Eppmann S, Kibies P, Hoffgaard F, Heil J, Menninger S, Ortiz-Cuaran S, Heuckmann JM, Tinnefeld V, Zahedi RP, Sos ML, Schultz-Fademrecht C, Thomas RK, Kast SM, Rauh D. Engel J, et al. Among authors: richters a. J Med Chem. 2015 Sep 10;58(17):6844-63. doi: 10.1021/acs.jmedchem.5b01082. Epub 2015 Aug 31. J Med Chem. 2015. PMID: 26275028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters